BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38173657)

  • 1. Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy.
    Pisani T; Cenci M
    Cancer Diagn Progn; 2024; 4(1):42-45. PubMed ID: 38173657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening.
    Cenci M; Rossi F; Pisani T
    In Vivo; 2023; 37(5):2161-2165. PubMed ID: 37652482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
    Ratnam S; Jang D; Alaghehbandan R; Gilbert L; Xu Y; Wang W; Andrews P; Green A; Speicher DJ; Chernesky M
    Cancer Biomark; 2023; 38(4):433-442. PubMed ID: 37980645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
    Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention.
    Tsimba Lemba PC; Boumba LMA; Péré H; Nganga PC; Veyer D; Puech J; Mboumba Bouassa RS; Malanda-Kiminou P; Moukassa D; Bélec L
    Infect Dis Now; 2023 Oct; 53(8):104762. PubMed ID: 37454761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.
    Piana A; Sotgiu G; Castiglia P; Pischedda S; Cocuzza C; Capobianco G; Marras V; Dessole S; Muresu E
    BMC Public Health; 2011 Oct; 11():785. PubMed ID: 21989375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China.
    Han C; Huang W; Ye M; Zou R; Lan J; Chen J; Jiang J; Wang H; Xia L; Luo J; Li D; Geng J; Wang Z; Huang J
    Front Public Health; 2023; 11():1225652. PubMed ID: 37701907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting.
    Akakpo PK; Ken-Amoah S; Enyan NIE; Agyare E; Salia E; Baidoo I; Derkyi-Kwarteng L; Asare M; Adjei G; Addo SA; Obiri-Yeboah D
    Infect Agent Cancer; 2023 May; 18(1):33. PubMed ID: 37237313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of Human Papilloma Virus (HPV) Genotype Prevalance and Distrubution in Adana: A Hospital-Based Study Between 2014-2021].
    Alışkan HE; Öğüç Şanlı Ö; Aka Bolat F; Alkaş Yağınç D; Toprak U
    Mikrobiyol Bul; 2023 Jan; 57(1):119-133. PubMed ID: 36636851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
    APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test.
    Youssef MA; Abdelsalam L; Harfoush RA; Talaat IM; Elkattan E; Mohey A; Abdella RM; Farhan MS; Foad HA; Elsayed AM; Elkinaai NA; Ghaith D; Rashed ME; Ghafar MA; Khamis Y; Hosni AN
    Infect Agent Cancer; 2016; 11():6. PubMed ID: 26889206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    Wang L; Wang P; Ren Y; Du J; Jiang J; Jia X; Chen C; Wang Y
    PLoS One; 2016; 11(8):e0160698. PubMed ID: 27494179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    Mboumba Bouassa RS; Nodjikouambaye ZA; Sadjoli D; Adawaye C; Péré H; Veyer D; Matta M; Robin L; Tonen-Wolyec S; Moussa AM; Koyalta D; Belec L
    PLoS One; 2019; 14(6):e0217486. PubMed ID: 31158254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.